Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities.
作者信息
Das Sudipto, Kelly Deirdre, Moran Bruce, Han Kathleen, Mulligan Niall, Barrett Ciara, Buckley Patrick G, McMahon Peter, McCaffrey John, Van Essen Hendrik F, Connor Kate, Lambrechts Diether, Ylstra Bauke, Gallagher William M, O'Connor Darran P, Kelly Catherine M
机构信息
, , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium.
出版信息
JCO Precis Oncol. 2017 Jun 5;1. doi: 10.1200/PO.16.00063. eCollection 2017.
Abstract
摘要
相似文献
1
Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities.
JCO Precis Oncol. 2017 Jun 5;1. doi: 10.1200/PO.16.00063. eCollection 2017.
2
The pathology of preclinical medullary thyroid carcinoma.
Endocr Pathol. 2004 Fall;15(3):227-31. doi: 10.1385/ep:15:3:227.
3
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7.
4
Atypical Presentation of a Medullary Thyroid Carcinoma Producing Acth and Serotonin.
Case Rep Oncol. 2019 Sep 27;12(3):742-748. doi: 10.1159/000502856. eCollection 2019 Sep-Dec.
5
SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.
6
Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
J Clin Endocrinol Metab. 2001 Aug;86(8):3746-53. doi: 10.1210/jcem.86.8.7767.
7
[Clinical significance and cost-benefit analysis of serum calcitonin assay in diagnosis and treatment of medullary thyroid carcinoma].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jul 7;54(7):506-509. doi: 10.3760/cma.j.issn.1673-0860.2019.07.005.
8
Coexistent familial nonmultiple endocrine neoplasia medullary thyroid carcinoma and papillary thyroid carcinoma associated with RET polymorphism.
Am J Med Sci. 2010 Jul;340(1):60-3. doi: 10.1097/MAJ.0b013e3181dfb245.
9
A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Endocr J. 1995 Apr;42(2):245-50. doi: 10.1507/endocrj.42.245.
10
The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.
Am J Otolaryngol. 2020 Jan-Feb;41(1):102312. doi: 10.1016/j.amjoto.2019.102312. Epub 2019 Nov 11.
引用本文的文献
1
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.
Clin Cancer Res. 2018 Feb 15;24(4):753-765. doi: 10.1158/1078-0432.CCR-17-2101. Epub 2017 Nov 29.
本文引用的文献
1
miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.
BMC Neurol. 2016 Dec 1;16(1):248. doi: 10.1186/s12883-016-0769-y.
2
Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
Sci Rep. 2016 Jul 14;6:29822. doi: 10.1038/srep29822.
3
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.
Oncology. 2016;90(6):339-46. doi: 10.1159/000445978. Epub 2016 May 21.
4
Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas.
Genes Chromosomes Cancer. 2016 May;55(5):418-27. doi: 10.1002/gcc.22344. Epub 2016 Feb 4.
5
Management of advanced medullary thyroid cancer.
Lancet Diabetes Endocrinol. 2016 Jan;4(1):64-71. doi: 10.1016/S2213-8587(15)00337-X. Epub 2015 Oct 23.
6
TRIM28 as an independent prognostic marker plays critical roles in glioma progression.
J Neurooncol. 2016 Jan;126(1):19-26. doi: 10.1007/s11060-015-1897-8.
7
Chromothripsis in cancer cells: An update.
Int J Cancer. 2016 May 15;138(10):2322-33. doi: 10.1002/ijc.29888. Epub 2015 Oct 30.
8
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
9
Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
Biochem Biophys Res Commun. 2015 Apr 10;459(3):379-86. doi: 10.1016/j.bbrc.2015.02.108. Epub 2015 Feb 27.
10
Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.
BMC Genomics. 2014 Jan 29;15:82. doi: 10.1186/1471-2164-15-82.
Zotero 插件